Supply and Demand Trading Made Simple With Astrazeneca StockIn the ever-evolving world of stock trading, where news headlines can shift markets in a heartbeat, savvy investors often turn to the age-old principles of supply and demand to find clarity. Enter AstraZeneca stock (NASDAQ: AZN) — a biopharmaceutical titan that has played a pivotal role in global health. It is a beacon for traders seeking to unlock the secrets hidden within its price movements.
There is a monthly demand level at $66 per share, which took control last November 2024. It's the end of January 2025, and the stock is rallying as expected.
Astrazenpharma
Science Backed by Data[AstraZeneca Series]: Target 3949Good Evening Friends,
AstraZeneca is in very long term uptrend(24 months). It has breaken out today after consolidating for past few 3-4 weeks. Breakout has been on very health volumes almost 4.5 times average volumes(331K vs 78K average volume)
RSI is in uptrend and looks promising.
Buy Closer to 3576 levels
Support Levels
2939 (below this trend may get invalidated on short term)
3302
3451
3520
3565
Target
1st Target 3949 ,
2nd target 4188
Pls support with likes on the idea.